Star Source Multi Trade

Star Source Multi Trade

139.80

-139.85

(-100.00%)

Market Cap

21.00 Cr

PE Ratio

-1.72

Volume

0.00

Day High - Low

- - -

52W High-Low

152.90 - 63.05

compare with

Sun Pharmaceutical

1,753.30 (-0.39%)

Divis Laboratories

6,696.50 (+0.81%)

Torrent Pharmaceuticals

3,962.10 (+0.64%)

Cipla

1,497.20 (-2.19%)

Dr Reddys Laboratories

1,250.70 (-0.44%)

Key Fundamentals

Market Cap

21.00 Cr

EPS

-9.66

PE Ratio

-1.72

PB Ratio

14.59

Book Value

9.58

EBITDA

-1.30

Dividend Yield

0.00 %

Industry

Sector

Pharmaceuticals

Return on Equity

-39.44

Debt to Equity

0.00

Actual

Company News

Star Source Multitrade Changes Website Domain

1 day ago

Star Source Multitrade Limited announces transition from old Chemo Pharma domain to new corporate website, ensuring compliance with SEBI regulations and seamless user access.

Citric India Limited Requests Reclassification from Promoter Group to Public Shareholder in Starsource MultitradeDec 03, 2025

Citric India Limited, a promoter group shareholder of Starsource Multitrade Limited, has requested reclassification to public shareholder status under SEBI regulations, citing zero equity shareholding and no control over company affairs. The request includes undertakings to comply with regulatory conditions and maintain the reclassified status for at least three years.

Star Source Multitrade Reports Loss of Rs 117 Crore in Half-Year ResultsNov 14, 2025

Star Source Multitrade Limited (formerly Chemo Pharma Laboratories) reported a net loss of Rs 117,070.51 thousand for the half-year ended September 30, 2025, compared to a profit of Rs 8,566 thousand in the previous year. The company generated revenue from operations of Rs 5,256.56 thousand in the latest quarter with total expenses of Rs 122,534.19 thousand for the half-year period.

View more

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,753.30	#1 4,20,675.40	40.28	#1 54,729.00	9.71	#1 10,980	2.89	53.13
Divis Laboratories	6,696.50	1,77,771.03	70.98	9,712.00	18.67	2,191	35.10	63.15
Torrent Pharmaceuticals	3,962.10	1,34,095.47	62.26	11,539.40	6.99	1,911	30.46	71.28
Cipla	1,497.20	1,20,939.59	22.75	28,409.50	7.12	5,291	3.71	57.84
Dr Reddys Laboratories	1,250.70	1,04,387.22	#1 18.27	33,741.20	16.73	5,725	-0.38	46.16
Lupin	2,162.50	98,782.74	22.61	22,909.50	13.74	3,306	#1 72.75	63.46
Zydus Life Science	930.35	93,614.98	18.63	23,511.00	18.55	4,615	34.60	54.52
Mankind Pharma	2,251.20	92,930.68	52.17	12,744.20	#1 20.90	2,007	-21.05	56.13
Aurobindo Pharma	1,231.20	71,508.30	20.91	32,345.60	9.43	3,484	3.81	60.21
Alkem Laboratories	5,675.50	67,859.12	28.04	13,458.30	3.70	2,216	10.98	55.49

Growth Rate

Revenue Growth

-

Net Income Growth

-

Cash Flow Change

-101.57 %

ROE

-

ROCE

-

EBITDA Margin (Avg.)

-

Yearly Financial Results

Annual Financials	2016	TTM
Revenue	-1	0
Expenses	0	0
EBITDA	-1	0
Operating Profit %	0 %	0 %
Depreciation	0	0
Interest	0	0
Profit Before Tax	-1	0
Tax	0	0
Net Profit	-1	0
EPS in ₹	-9.66	0.00

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2016
Total Assets	4
Fixed Assets	0
Current Assets	2
Capital Work in Progress	0
Investments	0
Other Assets	4
Total Liabilities	4
Current Liabilities	0
Non Current Liabilities	0
Total Equity	4
Reserve & Surplus	2
Share Capital	2

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2016
Net Cash Flow	0
Investing Activities	2
Operating Activities	-2
Financing Activities	0

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025
Promoter	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %	27.89 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
DIIs	0.28 %	0.17 %	0.17 %	0.17 %	0.17 %	0.17 %	0.37 %	0.37 %	0.37 %	0.17 %	0.37 %	0.17 %	0.37 %	0.37 %	0.37 %	0.37 %	0.37 %	0.37 %	0.37 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	65.76 %	65.77 %	65.51 %	65.70 %	65.74 %	65.72 %	65.57 %	65.38 %	65.40 %	65.56 %	65.55 %	65.51 %	65.61 %	65.63 %	65.60 %	65.50 %	65.29 %	65.77 %	65.66 %
Others	6.07 %	6.17 %	6.44 %	6.25 %	6.21 %	6.22 %	6.18 %	6.37 %	6.35 %	6.39 %	6.19 %	6.44 %	6.14 %	6.12 %	6.15 %	6.25 %	6.46 %	5.98 %	6.09 %
No of Share Holders	5,949	6,082	6,129	6,213	6,225	6,226	6,226	6,274	6,289	6,268	6,275	6,254	6,262	6,254	6,382	6,576	6,510	6,422	6,409

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
23 Sept 2024	Annual General Meeting	NA	23 Sept 2024	73.50	69.41
28 Oct 2024	Quarterly Result Announcement	NA	28 Oct 2024	72.10	67.00
27 Jan 2025	Quarterly Result Announcement	NA	27 Jan 2025	101.90	89.50
29 May 2025	Quarterly Result Announcement	NA	29 May 2025	124.45	147.65
12 Aug 2025	Quarterly Result Announcement	NA	12 Aug 2025	126.80	141.55
24 Sept 2025	Change Of Name	NA	24 Sept 2025	121.90	121.90
24 Sept 2025	Annual General Meeting	NA	24 Sept 2025	141.55	121.90
13 Nov 2025	Quarterly Result Announcement	NA	13 Nov 2025	116.00	125.00

Announcements

Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015

Change In Domain Name Of Website Of The Company

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Change in Management

Intimation Of Receipt Of No-Objection Letter For Reclassification Of Promoter(S) /Promoter Group Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Intimation Of Receipt Of Request For Reclassification From Promoter Group Shareholder To Public Shareholder Under Regulation 31A Of The SEBI (LODR) Regulations 2015

Announcement under Regulation 30 (LODR)-Newspaper Publication

Results For The Quarter And Half Year Ended September 30 2025

Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025

Board Meeting Intimation for For Considering And Approving Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025

Updates on revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Announcement under Regulation 30 (LODR)-Change of Company Name

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Change in Management

Shareholder Meeting / Postal Ballot-Scrutinizers Report

Shareholder Meeting / Postal Ballot-Outcome of AGM

Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of Promoter/Promoter Group From Promoter Group Category Shareholder To Public Category Shareholder Under Regulation 31A Of SEBI (LODR) Regulation2015

Appointment of Company Secretary and Compliance Officer

Announcement under Regulation 30 (LODR)-Newspaper Publication

Notice Of 83Rd AGM Scheduled On 24Th September 2025

Reg. 34 (1) Annual Report.

Announcement under Regulation 30 (LODR)-Newspaper Publication

Board Meeting Outcome for Intimation Under Regulation 31A Of The SEBI (LODR) Regulations 2015 For Reclassification From Promoter /Promoter Group To Public

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 22 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation Of Book Closure And Record Date For The Annual General Meeting To Be Held For The Financial Year 2024-2025

Submission Of Un-Audited Financial Results For The Quarter Ended June 30 2025

Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday August 12 2025.

Intimation Of Receipt Of Request For Reclassification From Promoter Group Shareholder To Public Shareholder Under Regulation 31A Of The SEBI (LODR) Regulations 2015

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015

Board Meeting Outcome for Outcome Of Board Meeting. INTIMATION OF APPOINTMENT OF STATUTORY AUDITOR

Board Meeting Intimation for Board Meeting Intimation

Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Atibha Agriseeds Private Limited

Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Shanta Somani

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Atibha Agriseeds Private Limited

Closure of Trading Window

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Citric India Limited

Intimation Of Appointment Of Secretarial Auditor

Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015

Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Updates on Open Offer

Technical Indicators

RSI(14)

Neutral

63.04

ATR(14)

Less Volatile

15.77

STOCH(9,6)

Neutral

56.30

STOCH RSI(14)

Overbought

97.28

MACD(12,26)

Bullish

3.30

ADX(14)

Strong Trend

25.17

UO(9)

Bearish

57.09

ROC(12)

Uptrend And Accelerating

13.15

WillR(14)

Neutral

-25.64